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ABSTRACT 
Objective: Essential oils are of significant interest in today’s world of healthcare because these compounds have a variety of medicinal properties. 
In this study, we evaluated the in vitro antibiotic role of essential oils as a possible alternative treatment in combatting Methicillin-resistant 
Staphylococcus aureus (MRSA). 
Methods: In conjunction with carrier oils, three essential oils (cassia, cinnamon bark, and thyme), as well as methylglyoxal were tested on MRSA 
using the Kirby-Bauer disc diffusion method.  
Results: The minimum inhibitory concentration of each tested essential oil and methylglyoxal in carrier oil was determined to be 25% essential oil 
and 75% carrier oil mixture. This concentration worked much more effectively than the standard antibiotic, vancomycin, which is currently used to 
treat MRSA infections. 
Conclusion: Antibacterial emollients made from naturally occurring products like essential oils can be cost-effective alternatives to antibiotics. The 
results of this research show that these emollients are more effective against MRSA than standard antibiotics in cell culture. 
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Antibiotics have long been the “go-to” treatment for pathogenic 
bacterial infections [1]. Common antibiotics, such as penicillin and 
methicillin, have been used since the mid-1900’s. These antibiotics, 
once effective medications for treating bacterial infections, have 
rapidly become less useful due to the highly adaptive genomes of 
pathogenic bacteria [2]. Bacterial genomes contain plasmids, which 
are small, circular, extracellular pieces of DNA that allow the 
bacterium to evolve quickly and adapt to its environment [3]. As 
antibiotics were being used, and oftentimes, misused, many bacterial 
species developed a resistance gene against the antibiotic within its 
plasmid DNA [4].  
Antibiotic resistant bacteria are receiving national attention in the 
United States. The White House and the CDC are working tirelessly to 
find ways to help prevent the antibiotic resistant bacteria pandemic 
from worsening by releasing an annual update on the matter to the 
public. In the latest 2014 update, the White House released this 
statistic: “[The CDC estimates that] annually at least two million 
illnesses and 23,000 deaths are caused by antibiotic-resistant bacteria 
in the United States alone” [5]. Scientists have been researching for 
years for effective ways to treat such infections like MRSA that are 
resistant to common antibiotics, resulting in the creation of newer 
classes of FDA-approved antibiotics which are costly and possibly 
short-lived in efficacy as it has been seen with earlier antibiotics. 
Antibiotics can kill bacteria, both helpful and pathogenic, within an 
organism. Broad-spectrum antibiotics have severe side effects in 
many patients who are taking them. These side effects include 
nausea, vomiting, diarrhea, numbness, urinary retention, and even 
the possibility of becoming more susceptible to other infections due 
to the fact that the body’s microbiota (like E. coli, Lactobacillus 
species) are being destroyed along with the pathogenic bacteria. 
With options growing thin and unpleasant, some scientists have 
turned towards natural products, such as essential oils, for therapy.  
Plants and their derivatives have been used for medicinal purposes 
as far back as the Egyptian civilizations in 2800 BC [6]. Essential oils 
are chemical compounds that can be hydrocarbons or oxygenated 
compounds like esters, aldehydes, alcohols, and phenols that are 
derived from plants. For therapeutic purposes, essential oils are 
usually diluted in a carrier before being applied to the skin to 
prevent irritation [6]. In this study, the essential oils cassia, 
cinnamon bark, and thyme as well as a key ingredient in Australia’s 
popular Manuka honey, methylglyoxal, were being tested for efficacy 
as emollients with several carrier oils in treating MRSA infections.  
These essential oil compounds showed promise against antibiotic 
resistant bacteria in previous studies conducted at Monmouth 
University [7-8]. These studies showed that essential oil emollients 
could be excellent alternative treatments for topical infections 
caused by antibiotic-resistant bacteria.  
MATERIALS AND METHODS 
Bacterial strains and growth conditions 
MRSA samples were supplied by Dr. Albert Rojtman, Chief of Clinical 
Microbiology at Jersey Shore University Medical Center in Neptune, 
NJ, USA. The anonymous samples were originally cultured on blood 
agar plates. For experimentation, the bacteria were grown under 
aerobic conditions on Mueller Hinton II agar media over a 24 hour 
incubation period at 37 °C.  
Obtaining essential oils 
Methylglyoxal (40% in H2
Obtaining carrier oils 
O) was obtained by mail order from Sigma 
Aldrich® of St. Louis, MO, USA. Cassia, cinnamon bark, and thyme 
were obtained by mail order from dōTERRA Essential Oils® of 
Pleasant Grove, UT, USA. 
Jojoba oil was obtained by mail order from Sigma Aldrich® of St. 
Louis, MO, USA. Coconut oil was obtained by mail order from 
dōTERRA Essential Oils® of Pleasant Grove, UT, USA. Liquid 
Lanolin was obtained by mail order from Now® Solutions of 
Bloomingdale, IL, USA. Olive oil (Filippo Berio®) was purchased 
at the local supermarket. All four carrier oils are safe for use on 
skin.  
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Standard antibiotics utilized 
Vancomycin susceptibility test discs (30 μg) and rifampin 
susceptibility test discs (5 μg) were obtained by mail order from 
Becton, Dickinson and Company of Franklin Lakes, NJ, USA.  
Preparation of mueller hinton II agar medium 
Mueller Hinton II agar was purchased by mail order from Becton, 
Dickinson and Company of Franklin Lakes, NJ, USA. Mueller Hinton II 
agar was chosen as a nutritive source for growing the MRSA bacteria 
as well as its suitability for performing susceptibility testing. The 
media was prepared as per manufacturer’s instructions under 
sterile conditions. Prepared media plates were stored at 4 °C until 
ready for use. 
Kirby-bauer disc diffusion 
A single MRSA colony from the blood agar plate provided by JSUMC 
was reconstituted in tryptic soy nutrient broth to match a 0.5 
McFarland standard 1 x 108
Standard antibiotic 
 colony forming unit per milliliter 
(CFU/ml) volume. The broth culture was then swabbed onto the 
Mueller Hinton II agar plates.  
Sterile blank 6 mm paper discs were placed in the center of each 
swabbed plate. A volume of 5 µl of each emollient was pipetted onto 
the blank disc. Vancomycin (30 µg) and rifampin (5 µg) antibiotic 
susceptibility test discs were also placed on swabbed plates to act as 
controls. After a 24 hour incubation period at 37 °C, the diameters of 
zones of inhibition around each disc were measured in millimeters [9]. 
The experiments were performed in triplicate and the zone of 
inhibition measurements were averaged to yield a mean zone of 
inhibition.  
RESULTS AND DISCUSSION  
Antibiotic discs of both vancomycin (30 µg) and rifampin (5 µg) 
were both tested against the MRSA in every experiment. 
Vancomycin averaged a zone of inhibition of 19 mm and rifampin 
averaged a zone of inhibition of 36 mm (table 1). Rifampin is used as 
an adjuvant only in very severe cases of MRSA when biofilm 
formation is suspected, so vancomycin is still the current standard of 
care [10]. However, it is apparent that vancomycin is losing its 
effectiveness against MRSA because a growing number of MRSA 
infections are showing antibiotic treatment failures. 
 
Table 1: Mean diameter of zone of inhibition of standard 
antibiotics used to treat MRSA 
Mean diameter of zone of 
inhibition (mm) 
Vancomycin 19  
Rifampin 36 
 
In order to effectively determine the minimum inhibitory 
concentration (MIC) of the essential oils, the experiments began by 
testing a concentration of 100% of each carrier oil against the MRSA 
to determine that the carriers chosen did not show any antibacterial 
effect of their own against the MRSA. A volume of 5 µl of fractionated 
coconut oil, jojoba oil, lanolin oil, and olive oil was pipetted onto a 
sterile blank paper disc and tested in triplicate against the MRSA. All 
proved to have no antibacterial properties because there was no 
zone of inhibition surrounding each carrier oil disc in every trial 
(table 2).  
 
Table 2: Mean diameter of zone of inhibition of carrier oils at 
100% concentration used against MRSA 





Jojoba oil 0.0 
Lanolin oil 0.0 
Olive oil 0.0 
 
Once the carrier oils were proved to have no bactericidal properties, 
5 µl of the essential oils were tested at 100% concentration to show 
that each essential oil chosen did, in fact, show antibacterial 
properties specific to MRSA. Each of the three essential oils, cassia, 
cinnamon bark, and thyme, as well as methylglyoxal, the main 
component of Australia’s popular Manuka honey, all formed large 
zones on inhibition that were larger than the zones of inhibition of 
both tested antibiotics (table 3).  
 
Table 3: Mean diameter of zone of inhibition of essential oils at 
100% concentration used against MRSA 
Essential oil Mean diameter of zone of inhibition (mm) 
Cassia 40.3 




The essential oil concentration was halved to 50% for the first 
dilution trial. The remaining 50% of the volume contained one of the 
four carrier oils. Each essential oil was tested in combination with 
each of the four carriers against the MRSA. Dilution was necessary 
because although in this experiment emollients were not being 
tested on skin, essential oils at their full concentration are normally 
known to be very irritant on the skin and would not be a feasible 
treatment on an open wound, like a MRSA infection.  
Table 4a: Mean diameter of zone of inhibition of 50% essential oil and 50% carrier oil emollient against MRSA 
Essential oil Carrier oil Mean diameter of zone of inhibition (mm) 
Cassia Coconut 36.7 
Jojoba 44 
Lanolin 35 
Olive  38.3 
Cinnamon bark Coconut 31.3 
Jojoba 40.3 
Lanolin 33.7 
Olive  36.3 
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Hence, the goal of finding the lowest dilution concentration of 
essential oil emollient that would still be deemed more effective 
than the standard antibiotic. At a 50% dilution, both cassia, 
cinnamon bark, and methylglyoxal all worked significantly better 
than vancomycin based on measured zone of inhibition. Of those 
three, cassia and methylglyoxal worked the best, working as well or 
better than even the strong rifampin antibiotic. Thyme, an essential 
oil that worked well on its own, did not work well in conjunction 
with carrier oils (table 4a) and therefore was excluded from further 
dilution trials. 
Cassia, cinnamon bark, and methylglyoxal were chosen to continue 
the dilution trials. The essential oil concentration was halved once 
again to 25%. The remaining 75% of the emollient consisted of a 
carrier oil. Cassia, cinnamon, and methylglyoxal mixed with lanolin 
showed the weakest results. Although the results for lanolin carrier 
oil emollients were less effective overall than rifampin, this 
emollient still worked better than vancomycin. The strongest results 
were from cassia-jojoba oil, cassia-olive oil, methylglyoxal-olive oil, 
and methylglyoxal-coconut oil emollients, all of which continued to 
work more effectively than even rifampin (table 4b). 
 
Table 4b: Mean diameter of zone of inhibition of 25% essential oil and 75% carrier oil emollient against MRSA 
Essential oil Carrier oil Mean diameter of zone of inhibition (mm) 
Cassia Coconut 32 
Jojoba 39.7 
Lanolin 35.7 
Olive  39.3 
Cinnamon bark Coconut 25.7 
Jojoba 29.7 
Lanolin 25.3 
Olive  31.7 
Methylglyoxal Coconut 39 
Jojoba 35.3 
Lanolin 31 
Olive  38.7 
 
In a second trial, the essential oil concentration was halved to 12.5% 
with the remaining 87.5% as a carrier oil. In this trial, the results were 
clearly disappointing. The cassia and cinnamon bark emollients 
worked about as effectively as vancomycin. Methylglyoxal still had a 
slight advantage over vancomycin, but none of the emollients were 
nearly as effective as rifampin (table 4c). 
 
Table 4c: Mean diameter of zone of inhibition of 12.5% essential oil and 87.5% carrier oil emollient against MRSA 
Essential oil Carrier oil Mean diameter of zone of inhibition (mm) 
Cassia Coconut 20.3 
Jojoba 23.6 
Lanolin 20 
Olive  20.3 
Cinnamon bark Coconut 13 
Jojoba 22.6 
Lanolin 19.3 
Olive  18 





At 25% dilution, all of the emollients worked significantly better 
than the vancomycin antibiotic. Several of the emollients at this 
concentration continued to exceed the results of rifampin. The 
results from the lowest dilution concentration (12.5%) were 
unremarkable. Of the 25% dilutions, four had results that 
particularly stood out: cassia-jojoba oil, cassia-olive oil, 
methylglyoxal-olive oil, and methylglyoxal-coconut oil. All four of 
these emollients surpassed not only the vancomycin standard but 
also the rifampin antibiotic (fig. 1). Thus, the MIC of these essential 
oils were concluded to be 25%.  
The structures of methylglyoxal and cinnamaldehyde, (which is the 
main active ingredient that makes up 75-90% of cassia), contain 
aldehyde structures (fig. 2a, 2b). Aldehydes have been known to 
confer antimicrobial activity and have been an important component 
of laboratory disinfectants for years because of their ability to 
quickly and effectively kill pathogenic bacteria. Aldehydes act by 
inhibiting and preventing peptide and protein synthesis, and a 
bacterial cell that cannot make more proteins cannot persist [11]. 
The fact that these two essential oils contain aldehyde structures 
may help explain their antibacterial activity. 
 
Fig. 1: Zone of inhibition (mm) plotted against 25% essential 
oil, 75% carrier oil emollients with reference to standard 
antibiotics 
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Fig. 2a-b: Structures of methylglyoxal, cinnamaldehyde (the 




Antibacterial emollients made from naturally occurring products 
like essential oils can be cost-effective alternatives to antibiotics. As 
a natural product that would be used on the skin, it could also 
potentially prevent the unpleasant side effects that go along with 
taking traditional antibiotics. This can also provide a possible 
alternative for those who prefer more natural methods of treatment, 
and for underserved populations that do not have access to or 
cannot afford other means of care. Cassia and methylglyoxal, have 
proven themselves in this study to have strong bactericidal 
properties at concentrations as low as 25% in carrier oil emollients, 
working even better than the current standard of care, vancomycin.  
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